AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2008
Jun 25, 2008
35134_dirs_2008-06-25_b89e5cc5-5570-4e62-b68a-7c1a48aefb71.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CROFF ENTERPRISES INC (COFF)
CIK: 0000025743
Period of Report: 2008-06-17
Reporting Person: Terrace Lane, LLC (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| $.10 par value common stock | 646000 | Direct |
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16